Diadema Partners’s Tenaya Therapeutics TNYA Stock Holding History

Diadema Partners’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-315,519	Closed	-$511K	–	196
2025 Q3	$511K	Buy	+315,519	New	+$318K	0.13%	99

Other funds holding TNYA

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BGM

Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $141M AUM

Diadema Partners's TNYA Position: Q4 2025 in Review

Diadema Partners sold out of Tenaya Therapeutics (TNYA) in Q4 2025, closing a stake of 315,519 shares — an estimated $511K sold.

Diadema Partners first reported a position in TNYA in Q3 2025 and held it in 1 quarter. The position peaked at $511K in Q3 2025. 97 funds tracked by Wall St. Rank hold TNYA as of Q4 2025.

Diadema Partners reported no remaining Tenaya Therapeutics position as of Q4 2025 after selling out during the quarter.
Diadema Partners sold 315,519 Tenaya Therapeutics shares in Q4 2025, an estimated $511K.
Diadema Partners first reported a position in Tenaya Therapeutics in Q3 2025 and held it in 1 quarter.
Diadema Partners's Tenaya Therapeutics position peaked at $511K in Q3 2025.
97 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q4 2025.

Based on Diadema Partners's 13F filing for Q4 2025, filed 17 Feb 2026.